Skip to main content

Table 1 Patients’ characteristics according to absence or presence of AAA

From: Prevalence of abdominal aortic aneurysm and associated lower extremity artery aneurysm in men hospitalized for suspected or known cardiopulmonary disease

 All patients (n = 566)No AAA (n = 526, 92.9%)AAA ≥ 30 mm (n = 40, 7.1%)p-value
Age (median, IQR)78.0 [72.0–82.0]77.0 [72.0–82.0]78.5 [74.8–83.0]0.41
 Heart rate (bpm)74.9 ± 14.675.0 ± 14.873.4 ± 12.00.51
 RR sys (mmHg)140.3 ± 19.3140.5 ± 19.2138.0 ± 20.70.43
 RR dia (mmHg)80.4 ± 11.180.5 ± 11.279.1 ± 10.80.44
 Total cholesterol (mg/dl)132.1 ± 43.9131.9 ± 43.8137.2 ± 49.70.72
 LDL (mg/dl)91.7 ± 32.791.8 ± 32.788.0 ± 32.90.73
Comorbidities, n (%)
 Hyperlipidemia370 (65.4)339 (64.4)31 (77.5)0.11
 Hypertension470 (83.0)433 (82.3)37 (92.5)0.10
 History of smoking327 (57.8)294 (55.9)33 (82.5)0.01
 Diabetes mellitus251 (44.3)240 (45.6)11 (27.5)0.03
 CAD393 (69.4)360 (68.4)33 (82.5)0.01
 Coronary 3-vessel-disease194 (34.3)168 (31.9)26 (65.0)<  0.0001
 Chronic kidney disease (GFR < 60 ml/min)340 (60.1)311 (59.1)29 (72.5)0.14
Main diagnosis, n (%)
 ACS246 (43.5)224 (42.6)22 (55.0)0.13
 Heart failure182 (32.2)174 (33.1)8 (20.0)0.09
 Exacerbation of COPD/ Pneumonia68 (12.0)63 (12.0)5 (12.5)0.92
 Others31 (5.5)28 (5.3)3 (7.5)0.56
Main symptoms, leading to hospital admission, n (%)
 Angina pectoris166 (29.3)155 (29.5)11 (27.5)0.79
 Dyspnea208 (36.7)189 (35.9)19 (47.5)0.14
 Palpitations/ Syncope104 (18.4)99 (18.8)5 (12.5)0.32
 Others35 (6.2)34 (6.5)1 (2.5)0.32
Concomitant medication, n (%)
 Betablocker331 (58.5)308 (58.6)23 (57.5)0.90
 Calcium channel blocker100 (17.7)96 (18.3)4 (10.0)0.19
 ACE inhibitor/ ARB444 (78.4)411 (78.1)33 (82.5)0.52
 Statin375 (66.3)339 (64.5)36 (90.0)0.001
 Antiplatelet therapy312 (55.1)284 (54.0)28 (70.0)<  0.05
 VKA/ DOAC190 (33.6)177 (33.7)13 (32.5)0.88
  1. CAD coronary artery disease. GFR glomerular filtration rate. ACS acute coronary syndrome. COPD chronic obstructive pulmonary disease. IQR interquartile range